Panion & Bf Biotech Inc. (TPE:1760)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
60.40
+1.00 (1.68%)
Mar 10, 2026, 10:28 AM CST
-27.75%
Market Cap 5.09B
Revenue (ttm) 2.04B
Net Income (ttm) 174.37M
Shares Out 85.74M
EPS (ttm) 2.03
PE Ratio 29.26
Forward PE n/a
Dividend 1.80 (2.94%)
Ex-Dividend Date Jun 12, 2025
Volume 28,218
Average Volume 167,778
Open 60.60
Previous Close 59.40
Day's Range 60.40 - 60.70
52-Week Range 56.00 - 89.90
Beta -0.05
RSI 37.15
Earnings Date Mar 16, 2026

About Panion & Bf Biotech

Panion & Bf Biotech Inc., a biotechnology pharmaceutical company, provides western medicines, cosmetics, testing reagents, food and chemical products in Taiwan, the United States, China, Hong Kong, Macau, and internationally. The company offers products in the areas of antibody, respiratory, gastrointestinal, COVID-19 IVD, antigen, anti-aging, active pharmaceutical ingredients, disease treatment, prevention, and veterinary products. It also offers nephrology, dermatology, pain management, hospital and household sanitization, and personal hygien... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1976
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 1760
Full Company Profile

Financial Performance

In 2024, Panion & Bf Biotech's revenue was 2.03 billion, an increase of 7.85% compared to the previous year's 1.88 billion. Earnings were 124.52 million, an increase of 61.26%.

Financial Statements

News

There is no news available yet.